# Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation

> **NCT02136875** · PHASE4 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 37 (actual)

## Conditions studied

- COPD
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Double dose of Salmeterol + Fluticasone Propionate
- **BEHAVIORAL:** Self-management education on the use of a self-administered prescription for exacerbation.
- **DRUG:** Self-administered prescription

## Key facts

- **NCT ID:** NCT02136875
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02136875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02136875, "Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02136875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*